DMI-Logo
search-iconsearch-icon

Others Research Reports & Consulting

Home
>
Reports
>
Pharmaceuticals
>
Others
Browse reports
DataM has exclusive market relevance and knowledge catering our services in 60+ industries
SUB CATEGORIES
All PharmaceuticalsCardiovascularCentral Nervous SystemDermatologyEar Nose Throat DisordersGastrointestinalGenitourinary DisordersHematologyHormonal DisordersImmunologyInfectious DiseaseMetabolic DisorderDiabetes CareMouth And Dental DisordersPain ManagementMusculoskeletalNeurologyNon-Malignant DisordersNutritional DisordersOncologyOphthalmologyOther DiseasesAllergyRespiratoryWomen's and Male HealthWound Care TreatmentSyndromeOthers
FILTER
Geography
Publish Date
Themesdown
SORT
Upload Date
Upload Date
Price
Published: 2026 February 13
Rare Neuromuscular Disorders Market Forecast 2025–2033: Market Size, Growth Trends & Leading Companies
The global rare neuromuscular disorders market reached USD 6.13 Billion in 2024 and is projected to reach USD 11.91 Billion by 2033, growing at a CAGR of 7.8%
Starting from
$4350$3480
Published: 2026 April 29
US CAR-T Cell Therapy Market Forecast 2025–2033: Market Size, Growth Trends & Key Players
The US CAR-T Cell Therapy Market is expected to reach at a CAGR of 12.7% during the forecast period 2025-2033 | DataM Intelligence
Starting from
$3175$2540
Published: 2026 February 13
Hepatitis B & C Therapeutics Market (2025–2033)
Hepatitis B & C therapeutics market to reach US$ 20.83 Bn by 2033 at 3.4% CAGR, led by oral antivirals and NA/DAA classes; APAC fastest growth.
Starting from
$4350$3480
Published: 2026 April 23
Disease-Modifying Therapies (DMT) Market Size, Share & Forecast 2026–2033
The global disease-modifying therapies market size was US$ 165.88 Billion in 2025 and is expected to reach US$ 281.88 Billion by 2033
Starting from
$4350$3480
Published: 2026 February 20
India CAR-T Cell Therapy Market Size, Share & Forecast 2026–2033
India CAR-T cell therapy market to reach US$1.21B by 2033 at 9.7% CAGR, driven by NexCAR19, Qartemi approvals, and rising indigenous innovation.
Starting from
$3175$2540
Published: 2025 November 13
Global SCD/β-Thal Gene Therapy Outlook 2025–2033: Size, Trends, Key Players
SCD & β-thalassemia gene therapy market to reach US$380.42M by 2033 at 18.4% CAGR, led by CRISPR, ZYNTEGLO, CASGEVY, and rising approvals.
Starting from
$4350$3480
Published: 2026 May 05
Global Cystic Fibrosis (CF) Therapeutics Market Size, Share & Forecast 2026-2033
The global Cystic Fibrosis (CF) Therapeutics Market reached US$ 12.10 billion in 2025,, growing at a CAGR of 14.2% during the forecast period 2026–2033.
Starting from
$4350$3480
Published: 2025 November 13
Global HIV Therapeutics Market Size, Share & Forecast 2025–2033
HIV therapeutics market to reach US$57.56B by 2033 at 4.8% CAGR, led by long-acting injectables, single-tablet regimens, and wider treatment access.
Starting from
$4350$3480
Published: 2026 June 06
Inflammatory Diseases Biologics Market Size, Share, Growth and Forecast to 2035
Global inflammatory diseases biologics market valued at US$ 104.31 BN in 2025 is projected to reach USD 157.31BN by 2033 (5.3% CAGR). Growth driven by expanding indications, biosimilar launches, and rising autoimmune disease prevalence.
Starting from
$4350$3480
Published: 2026 April 09
Hematologic Malignancy Therapeutics Market (2025–2033)
Global hematologic malignancy therapeutics market valued at USD 77.06B in 2024 is projected to reach USD 154.32B by 2033 (8.0% CAGR). Growth driven by targeted therapy approvals, immunotherapy advances, and rising blood cancer prevalence.
Starting from
$4350$3480